Maxime Schmitt

Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin–eosin-based morphologic parameters from the WHO classification

Björn Konukiewitz, Maxime Schmitt, Miguel G. Silva et al. · British Journal of Cancer · 2021 · 43 citations · Full text

Medicine, Oncology, Pathology +17

Morphology Matters

Moritz Jesinghaus, Maxime Schmitt, Corinna Lang et al. · The American Journal of Surgical Pathology · 2021 · 41 citations

Medicine, Oncology, Pathology +17

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?

Björn Konukiewitz, Atsuko Kasajima, Maxime Schmitt et al. · Cancers · 2021 · 20 citations · Full text

Medicine, Oncology, Pathology +17

Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups

Maxime Schmitt, Miguel G. Silva, Björn Konukiewitz et al. · Cancers · 2021 · 18 citations · Full text

Medicine, Oncology, Pathology +17

DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms

Maxime Schmitt, Hanibal Bohnenberger, Detlef K. Bartsch et al. · Endocrine Pathology · 2025 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +17